-
Sarah Jackson had quit abusing drugs and was sober for six months before finding out she has hepatitis C. The Fort Wayne, Indiana mom says she was newly…
-
The Food and Drug Administration priority review voucher comes from a Canadian company that got it by developing a drug for leishmaniasis, a disease long neglected by pharmaceutical companies.
-
The new product brings several advances, but it also has a steep price tag, reported at $1,125 per tablet. Its maker reported billions in sales of a related drug approved last year.